MEDOCEF

This brand name is authorized in Cyprus, Romania

Active ingredients

The drug MEDOCEF contains one active pharmaceutical ingredient (API):

1 Cefoperazone UNII 7U75I1278D - CEFOPERAZONE

Cefoperazone, a third-generation cephalosporin, interferes with cell wall synthesis by binding to the penicillin-binding proteins (PBPs), thus preventing cross-linking of nascent peptidoglycan. Cefoperazone is stable to penicillinases and has a high degree of stability to many beta-lactamases produced by gram-negative bacteria.

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MEDOCEF Powder for solution for injection / infusion	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD12	Cefoperazone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W13676001, W13676002, W13677001, W13677002